ArticleBlood2012

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

Hiroki Torikai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.